The NCRI Lung Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of lung cancer. The group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for lung cancer patients.  

The NCRI Lung Group consists of an executive group, chaired by Dr Matthew Hattonwhich provides oversight of the research landscape and proactively identifies opportunities for the group. The NCRI Lung Group also has several subgroups that develop research in areas of strategic need. Members are competitively recruited to the executive group and subgroups twice a year.  

Group Chair: Dr Matthew Hatton

Samreen Ahmed, Consultant in Medical Oncology, University Hospitals of Leicester NHS Trust

Miranda Ashton, Clinical Research Fellow, University of Glasgow

Fiona Blackhall, Clinical Senior Lecturer and Honorary Consultant in Medical Oncology, Christie NHS Foundation Trust

Lynn Calman, Associate Professor, University of Southampton

Gary Cook, Professor of Clinical PET / Honorary Consultant in Nuclear Medicine, King’s College London (KCL)

Paul Cosford

Nicholas Counsell, Senior Statistician, Cancer Research UK (CRUK) London – Clinical Trials Unit @ University College London (UCL)

Philip Crosbie, Consultant in Respiratory Medicine and Honorary Senior Lecturer, Manchester University Hospitals NHS Foundation Trust

Sue Dyde, Ms, NIHR Cancer Research Network – London

John Edwards, Consultant Thoracic Surgeon, Sheffield Teaching Hospitals NHS Foundation Trust

Kevin Franks, Consultant Clinical Oncologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Alastair Greystoke, Senior Lecturer and Honorary Consultant in Medical Oncology, Newcastle University

Matthew Hatton, Consultant Clinical Oncologist, University of Sheffield

Frank McCaughan, Honorary Consultant Respiratory Physician & University Lecturer, University of Cambridge

Fiona McDonald, Consultant Clinical Oncologist, Royal Marsden NHS Foundation Trust

Mary O’Brien, Consultant in Medical Oncology, Royal Marsden NHS Foundation Trust

Iain Phillips, Clinical Research Fellow, Royal Surrey NHS Foundation Trust

Kieran Prior, Cancer Research UK (CRUK)

James Spicer, Professor of Experimental Cancer Medicine; Consultant Medical Oncologist, King’s College London (KCL)
Frank Sullivan, Professor of Primary Care Medicine & Head of Population & Behavioural Science, University of St Andrews
Peter Szlosarek, Clinical Senior Lecturer, King’s College London (KCL)
Igor Vivanco, Team Leader in Molecular Addictions, Institute of Cancer Research (ICR)
William Wallace, Consultant Histopathologist, NHS Lothian
Lynne Wright, , No affiliation